CG Oncology (CGON) IPO deck
CG Oncology is a privately held biopharmaceutical company that focuses on developing bladder-saving therapeutics for patients with bladder cancer.
![](/content/images/size/w1304/2024/01/CGON_01-1.png)
CG Oncology is a privately held biopharmaceutical company that focuses on developing bladder-saving therapeutics for patients with bladder cancer.